Calico Life Sciences Tech Stack
AI-driven drug discovery platform focused on aging biology and age-related diseases
Calico is an Alphabet-founded biotech R&D company building computational infrastructure for drug discovery in aging. The tech stack—PyTorch, JAX, TensorFlow, AlphaFold, alongside wet-lab tools like LC-MS, qPCR, and HPLC—reflects a dual-track approach: deep learning for target identification and sequence analysis paired with classical chemistry and molecular biology. The hiring mix is research-dominated (21 roles) with a small engineering contingent (4), typical of discovery-stage biotech, though the active adoption of AlphaFold and ML frameworks suggests computational leverage is becoming central to their screening and target validation pipeline.
Tech Stack 35 technologies
What Calico Life Sciences Is Building
◆Challenges
- Accelerating drug discovery feedback loop
- Translational drug development pipeline
- Random screening
- High-quality training data
- Computational predictions
- Scalable synthetic processes
- Process risk mitigation
- Accelerating clinical development
- Managing global registrations
- Inefficient medical writing processes
▲Active Projects
- Novel drug target identification for age-related cardiovascular diseases
- Design and train deep learning models for biological sequence analysis
- Advancing drug discovery programs
- Aging biology research
- Aging therapeutics development
- Translational biomarkers for novel targets in neurological/neuropsychiatric indications
- Experimental medicine studies to demonstrate proof-of-mechanism of novel targets in neuropsychiatric diseases
- Early clinical development plans to demonstrate proof-of-concept in neuropsychiatric indications
- Design-build-test-learn cycle
- Antibody discovery engine
Hiring Activity
Department
Seniority
Notable leadership hires: Medical Director